https://www.selleckchem.com/pr....oducts/Neratinib(HKI
ts with African descent who are diagnosed with DLBCL.Background Birth defects are established risk factors for childhood cancer. Nonetheless, cancer epidemiology in children with birth defects is not well characterized. Methods Using data from population-based registries in 4 US states, this study compared children with cancer but no birth defects (n = 13,111) with children with cancer and 1 or more nonsyndromic birth defects (n = 1616). The objective was to evaluate cancer diagnostic characteristics, including tumor type, ag
Like
Comment
Share
